SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001104659-20-120587
Filing Date
2020-11-02
Accepted
2020-11-02 17:17:47
Documents
44
Period of Report
2020-09-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q tm2033941-1_10q.htm 10-Q 281728
2 EXHIBIT 31.1 tm2033941d1_ex31-1.htm EX-31.1 12138
3 EXHIBIT 31.2 tm2033941d1_ex31-2.htm EX-31.2 12231
4 EXHIBIT 32.1 tm2033941d1_ex32-1.htm EX-32.1 4817
5 EXHIBIT 32.2 tm2033941d1_ex32-2.htm EX-32.2 5215
  Complete submission text file 0001104659-20-120587.txt   2063293

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT txac-20200930.xml EX-101.INS 237875
7 XBRL TAXONOMY EXTENSION SCHEMA txac-20200930.xsd EX-101.SCH 32138
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE txac-20200930_cal.xml EX-101.CAL 18542
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE txac-20200930_def.xml EX-101.DEF 122614
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE txac-20200930_lab.xml EX-101.LAB 236638
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE txac-20200930_pre.xml EX-101.PRE 193271
Mailing Address 200 BERKELEY STREET 18TH FLOOR BOSTON MA 02116
Business Address 200 BERKELEY STREET 18TH FLOOR BOSTON MA 02116 617-778-2500
Therapeutics Acquisition Corp. (Filer) CIK: 0001811764 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-39373 | Film No.: 201281298
SIC: 6770 Blank Checks